Cancer, Resistance, Rare diseases, Monoclonal antibodies, DSIPs.
It was created with the intention of providing treatment for people with recurrent cancer and orphan diseases (also known as rare diseases). Its drugs are based on monoclonal antibodies that block the function of secreted factors called dual SMAD inhibiting proteins (DSIPs). These DSIPs promote the immortality of conventional drug-resistant tumour cells and other immature cells present in other diseases with high unmet medical need.
DESCRIPTION
It was created with the intention of providing treatment for people with recurrent cancer and orphan diseases (also known as rare diseases). Its drugs are based on monoclonal antibodies that block the function of secreted factors called dual SMAD inhibiting proteins (DSIPs). These DSIPs promote the immortality of conventional drug-resistant tumour cells and other immature cells present in other diseases with high unmet medical need.
Keywords
Cancer, Resistance, Rare diseases, Monoclonal antibodies, DSIPs.
